본문 바로가기
KERD
논문KCI 등재

Determination of diphencyprone and its photo-degradation product incompounded preparations using HPLC

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

Diphencyprone (DPCP) is frequently used as a compounded preparation in dermatology for the treatment of alopecia and recalcitrant warts based on the immune reaction of skin allergy. However, DPCP is a non-recognized agent in Pharmacopoeia, because there are no criteria or analytical method for quality control of its powder and formulation. DPCP is unstable under light irradiation because as it easily decomposes to diphenylacetylene (DPA). This study aims to develop a simultaneous HPLC analytical method for analyzing DPCP and DPA in the raw materials and compounded preparation. The method required a C18 column (250 × 4.6 mm, 5 μm) at 40 °C with a mobile phase of (A) 0.01 M phosphoric acid in water and (B) acetonitrile at UV 220 nm. DPA conversion to DPCP in the powder and compounded preparations was accelerated after light exposure for 60 min. In addition, this resulted in different patterns depending on the wavelength of light and the formulation. That is, DPCP in compounded preparation was more unstable than that in the powder. However, the DPCP formulation in amber bottles was observed to remain stable, although the measured concentrations of DPCP were somewhat different from the nominal concentration of the compounded preparations. The control of the exact concentration is required for effective disease treatment, depending on the state of the patient. In conclusion, these results will be useful for the recognition of DPCP in Pharmacopoeia and new DPCP formulation development to prevent photodecomposition.

Abstract

Diphencyprone (DPCP) is frequently used as a compounded preparation in dermatology for the treatment of alopecia and recalcitrant warts based on the immune reaction of skin allergy. However, DPCP is a non-recognized agent in Pharmacopoeia, because there are no criteria or analytical method for quality control of its powder and formulation. DPCP is unstable under light irradiation because as it easily decomposes to diphenylacetylene (DPA). This study aims to develop a simultaneous HPLC analytical method for analyzing DPCP and DPA in the raw materials and compounded preparation. The method required a C18 column (250 × 4.6 mm, 5 μm) at 40 °C with a mobile phase of (A) 0.01 M phosphoric acid in water and (B) acetonitrile at UV 220 nm. DPA conversion to DPCP in the powder and compounded preparations was accelerated after light exposure for 60 min. In addition, this resulted in different patterns depending on the wavelength of light and the formulation. That is, DPCP in compounded preparation was more unstable than that in the powder. However, the DPCP formulation in amber bottles was observed to remain stable, although the measured concentrations of DPCP were somewhat different from the nominal concentration of the compounded preparations. The control of the exact concentration is required for effective disease treatment, depending on the state of the patient. In conclusion, these results will be useful for the recognition of DPCP in Pharmacopoeia and new DPCP formulation development to prevent photodecomposition.

참고문헌 (15)

  1. C. Bolduc, , Skin Therapy Letter, 5(5), pp.3~4 (2000)
  2. C. Bolduc, , Dermatologic. Therapy, 14, pp.306~316 (2001)
  3. K. G. Bulock, , J. Investig. Dermatol. Symp. Proc, 17(2), pp.16~18 (2015)
  4. D. Sotiriadis, , Clinic Experi. Dermatol., 32(1), pp.48~51 (2006)
  5. T. Ito, , J. Dermatol., 39, pp.11~17 (2012)
  6. J. Severson, , J. Cutan. Med. Surg., 5(1), pp.43~60 (2001)
  7. J. A. Upitis, , J. Cutan. Med. Surg., 6(3), pp.214~217 (2002)
  8. D. A. Buckley, , Brit. J. Dermatol., 145, pp.385~405 (2001)
  9. K. S. Chiang, , J. Invest. Dermatol. Symp. Proc., 17(2), pp.50~55 (2015)
  10. J. T. Shapiro, , J. Am. Acad. Dermatol., 29(5), pp.729~735 (1993)
  11. T. Yoshimasu, , Autoimmun. Rev., 15, pp.664~667 (2016)
  12. H. Vennekate, , Z. Phys. Chem., 225(9-10), pp.1089~1104 (2011)
  13. M. G. Wilkerson, , J. Am. Acad. Dermatol., 17, pp.606~611 (1987)
  14. M. G. Wilkerson, , J. Am. Acad. Dermatol., 11(5), pp.802~807 (1984)
  15. A. Poloukhtine, , J. Phys. Chem. A., 110(5), pp.1749~1757 (2006)

관련 논문AI추천

Diphenylcyclopropenone (DPCP) 면역요법으로 호전된 전두 탈모증 2 예김기홍, 김찬우, 문석기, 신동훈, 신영민, 최종수영남대학교 의과대학 · Journal of Yeungnam Medical Science2006 · 제23권 제2호Can the Cytokine Analysis of the Scales on Alopecic Patch Predict the Response to Diphenylcyclopropenone Treatment in Alopecia Areata Patients?문종혁, 반대현, 변지원, 신정현, 이시협, 최광성대한피부과학회 · Annals of Dermatology2018 · 제30권 제2호Rapid determination and quantification of hair-growth compounds in adulterated products by ultra HPLC coupled to quadrupole-orbitrap MSGihaeng Kang, Han Na Park, Hoil Kang, Ji Hyun Lee, Jongkook Lee, Nam Sook Kim, Seongsoo Park한국분석과학회 · 분석과학2019 · 제32권 제2호Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study강훈, 박진, 이영, 김경민, 김도영, 김문범, 김민성, 신현태, 유박린, 장용현, 최광성, 허창훈대한피부과학회 · Annals of Dermatology2024 · 제36권 제4호Qualitative and quantitative determination of oleanolic acid in a scalp tonic products by HPLC using response surface methodology for extraction optimization조종운, Jong-Seong Kang, Kyung Tae Kim, Lin Xi Cai, Sang-Hun Jung, Yan Zhao한국분석과학회 · 분석과학2019 · 제32권 제2호Structural evaluation of degradation products of Loteprednol using LC-MS/MS: Development of an HPLC method for analyzing process-related impurities of LoteprednolBikshal Babu Kasimala, Fathima Sayed, Lavanya Nagamalla, Rajesh Varma Bhupatiraju한국분석과학회 · 분석과학2024 · 제37권 제2호

이 간행물의 다른 논문 (4건)